this post was submitted on 21 Dec 2023
166 points (97.2% liked)
Science
13216 readers
61 users here now
Subscribe to see new publications and popular science coverage of current research on your homepage
founded 5 years ago
MODERATORS
you are viewing a single comment's thread
view the rest of the comments
view the rest of the comments
They do make medicine that benefit people, but they're going to optimize around profit. The biggest sellers are drugs for very common cancers and for conditions that require lifelong treatment like rheumatoid arthritis. Estimates vary widely, but it costs somewhere in the ballpark of $1 billion to bring a new drug to market.
It just doesn't make sense for a drug company to produce new antibiotics when the point is to stockpile backup antibiotics to use against antibiotic resistance. The point, after all, is to not sell the product so that it is most potent when it is needed. This is one of the areas where I think it's best for governments to chip in.